Nicolas Pichon, General Manager of Australian Biotherapeutics and Head of Biomanufacturing, shares how Servatus is innovating in the field of live biotherapeutics to address a wide range of health conditions, from IBS to insomnia. With a focus on developing a curated consortium of controlled bacteria, Servatus is pioneering new approaches to microbiome-based therapies, offering promising advancements in the biomanufacturing and therapeutic landscapes.
